SCHEMBL722582

SCHEMBL722582

CCCCCCCCCC(N)C[Si](OC)(OC)OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G1B P04054 1/20 0.46
PLA2G2A P14555 1/20 0.46
S1PR2 O95136 5/20 0.42
S1PR1 P21453 5/20 0.42
S1PR3 Q99500 5/20 0.42
S1PR4 O95977 4/20 0.42
OPRM1 P35372 1/20 0.41
SPHK1 Q9NYA1 2/20 0.39
LMNA P02545 2/20 0.39
CYP2D6 P10635 2/20 0.37
GMNN O75496 1/20 0.37
POLB P06746 1/20 0.37
THPO P40225 1/20 0.37
MTOR P42345 1/20 0.37
BLM P54132 1/20 0.37
KDM4E B2RXH2 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29523549 1.00 PLA2G1B (0.46) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
SCHEMBL10430335 0.82 LMNA (0.46) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
SCHEMBL2713877 0.82 LMNA (0.50) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
SCHEMBL28823224 0.82 LMNA (0.46) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
SCHEMBL16447008 0.82 LMNA (0.50) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL1123186 0.81 LMNA (0.49) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL1334525 0.81 LMNA (0.49) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL7909372 0.81 LMNA (0.49) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL1123383 0.81 LMNA (0.49) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL1335393 0.81 LMNA (0.49) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12280325-B2 Porous composite structure, method of preparing the same, article including the same, and air purifier including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2025-04-22 US claimed
US-20220370937-A1 POROUS COMPOSITE STRUCTURE, METHOD OF PREPARING THE SAME, ARTICLE INCLUDING THE SAME, AND AIR PURIFIER INCLUDING THE SAME POSTECH Research and Business Development Foundation (KR) 2022-11-24 US claimed
US-20110024759-A1 THIN FILM TRANSISTOR SUBSTRATE AND METHOD FOR FORMING METAL WIRE THEREOF SAMSUNG DISPLAY CO., LTD. (KR) 2011-02-03 US claimed
US-20070187690-A1 THIN FILM TRANSISTOR SUBSTRATE AND METHOD FOR FORMING METAL WIRE THEREOF SAMSUNG ELECTRONICS CO., LTD. (KR) 2007-08-16 US claimed
US-7211898-B2 cross-linked self-assembled monolayers between Si surface and metal wiring, thereby offering good adhesion ability and anti-diffusion ability SAMSUNG ELECTRONICS CO., LTD. (KR) 2007-05-01 US claimed
US-7097882-B2 Substrate for immobilizing physiological material, and method of fabricating same SAMSUNG SDI CO., LTD. (KR) 2006-08-29 US claimed
US-20060163582-A1 Thin film transistor substrate and method for forming metal wire thereof SAMSUNG DISPLAY CO., LTD. (KR) 2006-07-27 US claimed
US-6903177-B2 Oligomer for immobilizing physiological material, and composition for immobilizing physiological material comprising the same SAMSUNG SDI CO., LTD. (KR) 2005-06-07 US claimed
WO-2004061991-A1 THIN FILM TRANSISTOR SUBSTRATE AND METHOD FOR FORMING METAL WIRE THEREOF SAMSUNG ELECTRONICS CO., LTD. (KR) 2004-07-22 WO claimed
US-20030153069-A1 Oligomer for immobilizing physiological material, and composition for immobilizing physiological material comprising the same SAMSUNG SDI CO., LTD. (KR) 2003-08-14 US claimed
US-20030129740-A1 Method of preparing substrate having functional group pattern for immobilizing physiological material SAMSUNG SDI CO., LTD. (KR) 2003-07-10 US claimed
US-20030072951-A1 Substrate for immobilizing physiological material, and method of fabricating same SAMSUNG SDI CO., LTD. (KR) 2003-04-17 US claimed
EP-1291655-A2 Substrate for immobilizing physiological material and method of fabricating same Samsung SDI Co., Ltd. (KR) 2003-03-12 EP claimed
US-12280325-B2 Porous composite structure, method of preparing the same, article including the same, and air purifier including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2025-04-22 US disclosed
US-20220370937-A1 POROUS COMPOSITE STRUCTURE, METHOD OF PREPARING THE SAME, ARTICLE INCLUDING THE SAME, AND AIR PURIFIER INCLUDING THE SAME POSTECH Research and Business Development Foundation (KR) 2022-11-24 US disclosed
US-10352941-B2 Method for functionalizing a porous membrane covering of an optical sensor to facilitate coupling of an antithrom-bogenic agent MEDTRONIC MINIMED, INC. (US) 2019-07-16 US disclosed
US-20030072951-A1 Substrate for immobilizing physiological material, and method of fabricating same SAMSUNG SDI CO., LTD. (KR) 2003-04-17 US disclosed
CN-1407116-A Substrate fixing physiologically substance and its preparation SAMSUNG SDI CO LTD (KR) 2003-04-02 CN disclosed
EP-1291655-A2 Substrate for immobilizing physiological material and method of fabricating same Samsung SDI Co., Ltd. (KR) 2003-03-12 EP disclosed
US-5053048-A Thromboresistant coating CORDIS CORPORATION (US) 1991-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153069-A1 Oligomer for immobilizing physiological material, and composition for immobilizing physiological material comprising the same ILK, TNNC1, SUMO3 PLA2G1B 3761/4885PLA2G2A 3356/4885S1PR2 3531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.